Mice expressing IL-23 constitutively in the intestine or skin fail to grow and die prematurely. 
Introduction
The gut of a newborn mouse is immature, resembling that of a premature infant (Levy, 2007; Tanner et al., 2015) . It lacks cells specialized in antimicrobial defense, such as Paneth cells (Stappenbeck, 2009 ), contains few T and B cells, and it is populated mostly by myeloid immune cells (Levy, 2007; Marodi, 2006) . The lymphoid compartment at this stage is represented mostly by innate lymphoid cells (ILCs) that can respond to bacteria, and are important for formation of structures such as Peyer's patches and mesenteric lymph nodes (BarEphraim and Mebius, 2016) . Maturation of the intestinal barrier and the immune system appear to be dependent of colonization by commensal bacteria (Gensollen et al., 2016; Torow et al., 2017) . Colonization of the neonatal intestine starts at birth, with the newly acquired bacteria coming from the vaginal canal or skin, and triggering a complex interaction with cells of the immune system (Gensollen et al., 2016) . This process is further influenced by immunoregulatory factors present in the maternal milk (Maynard et al., 2012) .
Precise and balanced responses are performed by the cells of the innate immune system in the intestine of newborns, but in a number of occasions, the responses are not balanced, and significant immunopathology arises. One of the important regulators of myeloid and innate lymphoid cell biology is the cytokine interleukin 23 (IL-23) (Basha et al., 2014; Willems et al., 2009 ). Deficit in IL-23 signaling is not associated with a major deficit in the immune function in newborn mice, but overexpression of IL-23 in neonates has severe consequences, leading to premature death . Previous work from our group showed that early expression of IL-23 in the neonatal intestine promoted an increase in the number of type 3 innate lymphoid cells (ILC3), altered barrier function and promoted severe intestinal inflammation . To further understand the pathological consequences of IL-23 expression in early life, we generated two novel mouse strains. We show that expression of IL-23 by CX3CR1-positive cells leads to mortality in 50% of the mice within the first 48 h and that this process is driven by the microbiota, as there is a substantial extension of survival in germ-free conditions. Expression of IL-23 by the keratin-14 promoter also results in premature death, with mice succumbing before 15 days of age. The neonatal mortality associated with IL-23 expression is mediated by its downstream cytokine interleukin 22 . IL-22 expression in newborn mice affects expression of genes encoding antimicrobial peptides and digestive enzymes produced by the pancreas and intestine, resulting in a malabsorptive condition. The malabsorptive condition is due in part to downmodulation by IL-22 of the expression of the pancreas associated transcription factor 1a (Ptf1a), an important transcription factor required for the maintenance of acinar cell identity and function (Hoang et al., 2016; Walczak et al., 1975) . Deletion of IL-22 in mice expressing IL-23 constitutively reverses these changes and prevents early death.
Results

Constitutive expression of IL-23 in CX3CR1
+ cells results in early lethality. Animals expressing IL-23 from the villin promoter (V23 mice) die at birth . The cause of death appears related to intestinal bleeding originating from the small intestine. To further study the biology of IL-23 in neonates we engineered mice in which expression of IL-23 was targeted constitutively to CX3CR1 + cells, which are the cells that predominantly express IL-23 in the intestine. This was accomplished by intercrossing mice containing a IL-23 cassette preceded by a floxed STOP signal in the ROSA 26 locus (R23 mice) (Chen et al., 2018) , with mice containing a cre recombinase gene inserted into the CX3CR1 locus (CX3CR1-cre mice) (Yona et al., 2013) . We refer to these animals as CXR23 mice (Fig. 1a) . Expression of the IL-23 subunits p19 and p40 was detected in the intestine of the transgenic, but not control mice (Fig 1b) .
CXR23 mice were normal at birth, but approximately 50% of the pups died within the first 48
hours of life, with the remaining pups perishing before day 8 (Fig. 1c) . CXR23 mice had a normal body weight at birth, but did not grow after birth ( Fig. 1d and e) . Necropsy of the newborn mice showed the presence of blood within the small intestine, but not in other organs.
Histological analyses of the CXR23 intestine showed that the bleeding (Fig 1g) originated from disrupted villi and from cellular aggregates that resembled PP anlagen (Fig. 1j, dashed line) present in the WT small intestine (Fig. 1i) . The cellular aggregates in the CXR23 mice were rich in neutrophils that disrupted the overlaying epithelium (Fig 1h) , and in IL-22 + cells (Fig. 1J) , suggesting a role for these cells in pathology. Of note, the number of ILC3, capable of producing IL-22 and IL17 upon stimulation with IL-23, was markedly increased in the intestine of CXR23 mice compared to controls (Fig. 1k) . No abnormalities were found in the large intestine or other organs (kidney, heart, lung and brain) by conventional histological analyses (Supplemental Figure 1a) . These findings confirm our previous observations that IL-23 expression in the murine gut results in early lethality .
CXR23 germ-free mice have increased lifespan when compared to CXR23 SPF mice but die at an early age. Previous work from our lab suggested that expression of IL-23 could modify intestinal permeability and facilitate bacterial translocation during the immediate neonatal period . To investigate whether bacteria contributed to the phenotype of early lethality, we generated CXR23 mice in germ-free (GF) conditions. Most (>60%) of the CXR23 GF mice survived beyond day 10 in contrast to the CXR23 SPF mice, but succumbed by 30d of age (Supplemental Fig. 2a) . No bleeding was observed in the intestine of CXR23 GF mice at birth or later (Supplemental Fig. 2b ). Neutrophils were present in the small intestine, but did not disrupt the epithelium (Supplemental Fig. 2c) . Together, the results suggest that the newly acquired microbiota contributes to the development of the intestinal bleeding phenotype observed in CXR23 SPF neonates.
Early lethality in mice expressing IL-23 constitutively in the skin. To further investigate the factors contributing to early lethality and stunted body growth elicited by IL-23 expression, we engineered another transgenic strain in which expression of IL-23 was directed to the keratinocytes, by intercrossing the R23 mice with mice carrying a cre-recombinase driven by the K14 promoter (Fig. 2a) . These animals, which we refer to as KS23 mice, expressed higher levels of IL-23 in the skin than control littermates ( Fig. 2b and 2c ) and had normal body weight at birth. By day 5 KSR23 mice had milk in the stomach, but were smaller than their control littermates ( Fig. 2d and 2e ). Similar to CXR23 mice, KSR23 mice died prematurely (before 15 days of age, Fig. 2f ), but displayed no signs of disease in the skin, intestine, or in other organs examined (Supplemental Fig. 1b) . A notable finding in the animals was the presence of diarrhea, with yellow stools (Fig. 2g) , which suggested food malabsorption. Conditions that lead to malabsorption are associated with increased fecal fat content, commonly known as steatorrhea. To determine if KSR23 mice developed steatorrhea, we measured triglycerides (TG) in the stools and in the serum (Fig. 2h-i) . At day 5, KSR23 mice had increased fecal TG (Fig. 2h) and decreased TG levels in the serum (Fig 2i) Fig. 3 ). Serum levels of IL-22, IL17, IFNγ, IL1β, but not GMCSF, were significantly elevated in the serum of CXR23 mice (Supplemental Fig. 3 ). Levels of IL-22, IFNγ and IL-1β were significantly elevated in KSR23 mice (Fig. 2G) . In general the levels of cytokines in serum correlated with the levels of IL-23, with the changes being more marked in the CXR23 mice. The most up regulated cytokine in the serum of CXR23
and KSR23 mice was IL-22, whose overall levels reached 10 and 4 ng/ml, respectively. The markedly elevated levels of cytokines in serum suggested a possible role for these molecules in pathogenesis.
Genetic ablation of IL-22 or IL-22R reduces lethality and restores normal body growth in neonates expressing IL-23. To test if IL-22 had a role in the pathogenesis elicited by IL-23 in vivo, we intercrossed CXR23 and KS23 mice to IL-22 -/-mice generated in our laboratory (Supplemental Fig. 4) . and KSR23 (KSR23/IL-22 -/-) mice had extended life spans ( Fig. 3a and 3e ) and normal growth ( Fig. 3b and 3f ) suggesting that IL-22 had a major role in the stunted growth and lethality phenotypes exhibited by these animals. Of note, none of the IL-22-deficient CXR23 mice examined had intestinal bleeding (Fig. 3c) (Fig. 3a) , and had normal body weight at P4 (Fig.   3b ). Together these results indicate that IL-22 is the main cytokine driving neonatal pathology in mice expressing IL-23 at birth.
Increased expression of IL-23 and other cytokines affects expression of genes in neonatal intestine and pancreas. IL-23 and other cytokines were detected at higher levels in the serum of CXR23 and KSR23 mice than WT mice. We reasoned that these changes could have affected the growth of the newborn mice. Body growth in newborns is dependent on their ability to ingest, process, and absorb nutrients. Animals in both strains of transgenic mice had milk in the stomach, suggesting that food ingestion was not affected. To investigate if elevated cytokines could affect body growth, we examined the transcriptome of the pancreas (Fig. 4 ) and the intestine (Fig. 5) , organs that are critical for the processing and absorption of nutrients. To do so we extracted RNA from the pancreas and jejunum of 5 day-old mice expressing IL-23 in skin (KSR23 mice) and performed RNASeq.
As shown in Fig 4a and 4b , the transcriptome of the pancreas of KSR23 mice at P5 differed significantly from that of their control littermates. Kegg pathway analysis showed that several genes involved in pancreatic secretion, were downregulated (Fig. 4c) . The pancreatic secretion pathway includes genes encoding several pancreatic enzymes involved in food digestion and genes involved in the secretory pathway (Fig. 4c) . Among the genes downregulated in the KSR23 mice were those encoding pancreatic enzymes, including pancreatic amylases (amylase 2a, Amy2a; and amylase 2b, Amy2b), lipase (Pnlip), elastase (elastase 1, Cela1; elastase 2a, Cela2a), and proteases (carboxypeptidase 1, Cpa 1; carboxypeptidase 2, Cpa2; kallikrein 1-related peptidase b5, Klk1b5; chymotrypsin-like protease Ctrl; chymotrypsin C, Ctrc) (Fig. 4d) .
Other genes involved in pancreatic acinar secretion were also down regulated, including syncollin (Sycn), a protein that regulates the fusion of zymogen granules (Wasle et al., 2005) .
Aquaporin 12 (AQP12), an acinar specific water channel that controls secretion of pancreatic fluid (Itoh et al., 2005) , was also downmodulated in the pancreas of KSR23 mice (Fig. 4e) . Some of these changes were confirmed by qPCR (Fig. 4f) .
The transcription regulatory gene Ptf1a controls acinar cell secretory protein processing and packaging (Hoang et al., 2016) . Inactivation of Ptf1a in adult acinar cells results in decreased acinar cell identity and this coincides with the appearance of the ductal cell markers Sox9 and keratin19 (Hoang et al., 2016; Krah et al., 2015) . We observed decreased expression of Ptf1a (Fig. 5a) . Several genes were differentially expressed, including IL-22, and genes that are downstream of it such as Reg3 genes (Fig 5b) and digestive enzymes also produced by the jejunum. Kegg pathway analysis of WT and KSR23 jejunum indicated that genes involved in protein digestion and absorption such as chymotrypsinogen B1 (Ctrb1), trypsinogen (Prss1), trypsin (Tyr5 and Tyr4), caboxypeptidase a1 (Cpa1) and chymotrypsin-like elastase family member 3b (Cela3b), were downregulated in the intestine of KSR23 mice (Fig. 5c ). Transcriptome analysis also showed decreased expression of several genes involved in the regulation of the very low-density lipoprotein particle pathway (VLDL) ( Fig. 5d and 5e ). These particles regulate fat and cholesterol release into the bloodstream. Together, these results indicate that systemic expression of IL-23, and other cytokines, correlated with significant transcriptional changes in genes that regulate food processing in the pancreas and intestine.
IL-22 ablation corrects aberrant pancreatic enzyme gene expression observed in KSR23
mice. To ask if IL-22 affected the expression of pancreatic enzymes we examined the expression of several genes by in the pancreas of KSR23 and KSR23/IL-22 -/-mice.
Quantitative PCR confirmed that KSR23 mice had increased mRNA levels of Reg3β and decreased levels of pancreatic lipase, amylase and syncollin in the pancreas than that in WT controls (Fig. 6a, c , e, and g, respectively). Changes in protein levels were also documented by immunohistochemistry (Fig. 6b, d , f, and h). Deletion of IL-22 in KSR23 mice had a marked effect on the levels of expression of these genes (Fig. 6a, c , e, and g), as well as on the levels of pSTAT3, a known mediator of IL-22 signaling (Supplemental Fig. 6 ). Levels of Reg3β, amylase and pancreatic lipase, as well as syncollin in the pancreas of KSR23/IL-22 -/-mice were equivalent to those observed in WT mice (Fig. 6a, c , e, and g), suggesting that IL-22, or genes downstream of it, had a major role in controlling expression of pancreatic genes. Longer incubation of the acinar cells with IL-22 (60h) led to a significant decrease in the expression of Ptf1a (Fig. 7a) . Coincident with the decreased expression of Ptf1a we observed a significant decrease in the expression of Sycn, Amy2a and Prss2 in cultures stimulated with IL-22 ( Fig. 6) , suggesting a direct role for IL-22 in the regulation of these pancreatic genes. To confirm that these changes were elicited by IL-22 signaling, we studied the effect of IL-22 in pancreatic cells derived from IL10R2-deficient mice. No changes in gene expression were observed after addition of IL-22 to IL-22R signaling-deficient pancreatic acinar cells ( Fig. 7 and Supplemental Fig. 7) , confirming that the changes observed in the expression of pancreatic genes were mediated by the IL-22 receptor. Together these results indicate that the inhibition of pancreatic gene expression observed in KSR23 mice is mediated by IL-22.
IL-
Discussion
Here we study the impact of IL-23 expression in newborns. We report that IL-23 induces severe phenotypes when expressed since birth by CX3CR1 + cells and by keratinocytes. These phenotypes are reversed by inactivation of IL-22, suggesting that IL-22 mediates the pathogenic properties of IL-23 in newborns. We also show that a critical and unappreciated pathogenic mechanism triggered by IL-22 is the reduction in the expression of several pancreatic enzymes, which contributes to the failure to thrive observed in these animals. stimulation, it is likely that they are a major source of IL-22 in the newborn gut. Increased IL-22 levels could disrupt intestinal permeability, favor permeation of bacteria into the lamina propria, and cause marked intestinal inflammation and intestinal bleeding and death .
This hypothesis is supported by our observation that CXR23 germ-free mice survive beyond the first 48 h, and that IL-22 ablation rescues the early death phenotype.
The second phenotype observed in both strains was failure to growth. CXR23 mice that survived the first 48 hours failed to grow and died prematurely, similar to KSR23 mice. Again, these phenotypes were reversed by IL-22 ablation, indicating a pathogenic role for elevated levels of IL-22. Our results are in agreement with other findings in the literature. Transgenic expression of IL-22 from the EµLCK promoter or from the insulin promoter, results in animals with small body weight that die a few days after birth (Wolk et al., 2009 ). Expression of IL-22 from the albumin promoter, on the other hand, does not induce early lethality, but the body weight of the animals is lower than that of wild type littermates from 5 months of age on (Park et al., 2011) . The reason why animals in this line survive, and the other strains driven by the EµLCK and insulin (Wolk et al., 2009) , villin and CX3CR1 promoters do not, is unclear, but it might be related to overall levels of IL-22 in circulation or the site and timing of its expression. Low body weight is also observed in mice in which IL-22 was delivered by adenoviral infection or in animals injected daily with this cytokine (25 mg over a 2-wk period).
Daily injection of IL-22 induced a 8% decrease in body weight (Liang et al., 2010) . The causes of stunted growth and low body weight are multiple and include reduced absorption of dietary components. Indeed, it was suggested previously that IL-22 regulates expression of lipid transporters in the intestine (Mao et al., 2018 ), a finding that we confirm and extend here.
The most unexpected finding in the course of our experiments was that increased levels of IL-22 in circulation markedly affected the expression of pancreatic enzymes critical for digestion of carbohydrates, proteins and lipids. The reduced expression of enzymes and reduced absorption of nutrients by the intestine resulted in malabsorption, as evidenced by increased amount of fat in the stools. The expression of the digestive enzymes was normalized by deletion of IL-22.
Thus, it is likely that the growth disturbances observed in the CXR23 and KSR23 mice result in part from malabsorption of critical dietary components due to reduced expression of pancreatic enzymes and of intestinal transporters.
While we cannot rule out that the other cytokines simultaneously upregulated by IL-22 may impact the expression of the pancreatic and intestinal genes, our demonstration that IL-22 can directly downregulate expression of genes encoding the pancreatic enzymes in vitro, suggest that IL-22 is the main factor regulating this process in IL-23 expressing animals. We show here that incubation of acinar cells with IL-22 leads to a significant reduction in the expression of Ptf1a. Ptf1a is a basic helix-loop-helix transcription factor that is critical for the specialized phenotype of the pancreatic acinar cells, including the control of the production of secretory digestive enzymes (Krah et al., 2015) . We show an increase in the number of pSTAT3 acinar cells of the KSR23 mice and postulate that this may be the effector mechanism for the reduced expression of digestive enzymes. Interestingly, the genetic ablation of Ptf1a in adults leads to reduction in the expression of genes encoding acinar secretory products and genes involved in the zymogen granule formation (Hoang et al., 2016) . Also of interest is the observation that decreased Ptf1a expression results in increased expression of ductal cell markers (Hoang et al., 2016; Krah et al., 2015) . Similar results were observed in KSR23 mice. Our observations linking high systemic levels of IL-22 with reduced levels of Ptf1a expression in the pancreas of KS23 mice, and the demonstration of a direct activity of IL-22 on the acinar cell, strongly support a role for IL-22 in the expression of Ptf1a. (Barthet et al., 1999; Barthet et al., 2006; Bokemeyer, 2002) , and these may be functionally related to higher levels of IL-22 in situ or in circulation. Relevant to this discussion is the observation that pediatric IBD is often associated with growth failure (Diefenbach and Breuer, 2006) , which is caused by several factors among them decreased food intake and malabsorption (Rosen et al., 2015) .
In summary, we have demonstrated an important role for IL-23 in neonatal pathology. The main effector mechanism triggered by IL-23 is increased production of IL-22, which acts at the level of the intestinal epithelium and acinar cells in the pancreas to regulate intestinal permeability and inhibit mechanisms associated the digestion and absorption of nutrients. These results indicate that dysregulation in the expression of IL-23 and IL-22 has a significant negative impact on survival and overall fitness of newborns.
Methods
Mice. R23 mice were described in (Chen et al., 2018) . R23 mice were backcrossed into the C57BL/6 background for 11 generations. Generation of IL-22-deficient mice in the C57BL/6 background is described in Supplemental Fig. 4 . C57BL/6 (CN 000664), CX3CR1-cre (Yona et al., 2013 ) (CN 025524), hK14-cre (Dassule et al., 2000) (CN 018964), and IL10R2KO (Spencer et al., 1998 ) (CN 005027) mice were purchased from The Jackson laboratory (Bar Harbor, ME).
IL-22 tDt-tomato mice were provided by Dr. Scott Durham (NIH, Bethesda, MD). Mice were maintained under specific pathogen-free conditions. All experiments involving animals were performed following guidelines of the Animal Care and Use Committee of the Icahn School of Medicine at Mount Sinai.
Generation of IL-22-deficient mice. IL-22 deficient (IL-22
-/-) mice were generated using CRISPR/Cas9 technology directly into C57BL/6 as described before (Mashiko et al., 2013) . To do so, we designed a sgRNA that targeted IL-22 exon 1 by using the online CRISPR Design Tool (http://tools.genome-engineering.org). The plasmid expressing sgRNA was prepared by ligating oligos into BbsI site of pX330 (Addgene plasmid ID: 42230) (Ran et al., 2013) .
Confirmation of WT and KO genotypes was done by sequencing. Functional validation of the IL-22 knockout was done as described in Supplemental Fig. 4 .
Flow cytometry. The small intestine (SI) of P1 mice were microdissected using a stereo microscope, minced and digested with 2 mg ml Acinar cell culture. Pancreatic acinar cells were isolated as described (Gout et al., 2013) and cultured for 24 and 60 hours in Waymouth's medium alone or with addition of recombinant IL-22
(50 ng/mL, Kingfisher Biotech) at 37 °C, 5% CO 2 .
Reverse-transcription polymerase chain reaction. Total RNA from tissues was extracted using the RNeasy mini/micro Kit (Qiagen) according to the manufacturer's instructions.
Complementary DNA (cDNA) was generated with Superscript III (Invitrogen). Quantitative PCR was performed using SYBR Green Dye (Roche) on the 7500 Real Time System (Applied Biosystems) machine. Results were normalized to the housekeeping gene Ubiquitin. Relative expression levels were calculated as 2 (Ct(Ubiquitin)-Ct(gene)) . Primers were designed using Primer3Plus and are listed in Supplemental Figure 8 .
RNA-seq Small intestine and pancreas were homologized in Trizol reagent (Invitrogen). Total
RNA from tissues was extracted using the RNeasy mini Kit (Qiagen) according to the manufacturer's instructions. Samples were shipped on dry ice to the Center for Functional
Genomics and the Microarray & HT Sequencing Core Facility at the University at Albany (Rensselaer). RNA quality was assessed using the Nanodrop (Thermo Scientific) and Bioanalyzer Total RNA Pico assay (Agilent). Total RNA with a RNA integrity number (RIN) value of 8 or greater was deemed of good quality to perform the subsequent protocols. 100 pg of total RNA was oligo-dT primed using the SMART-Seq v4 Ultra Low Input RNA Kit (Clontech) and resulting the cDNA was amplified using 15 cycles of PCR. The double stranded cDNA (dscDNA) was purified using AMPure XP magnetic beads and assessed for quality using the Qubit dsDNA HS assay and an Agilent Bioanalyzer high sensitivity dscDNA chip (expected size ~600bp-9000bp). The Illumina Nextera XT kit was used for library preparation wherein 125 pg dscDNA was fragmented and adaptor sequences added to the ends of fragments following which 12 cycles of PCR amplification was performed. The DNA library was purified using AMPure XP magnetic beads and final library assessed using Qubit dsDNA HS assay for concentration and an Agilent Bioanalyzer high sensitivity DNA assay for size (expected range ~600-740bp).
Library quantitation was also done using a NEBNext Library Quant kit for Illumina. Each library was then diluted to 4nM, pooled and denatured as per standard Illumina protocols to generate a denatured 20 pM pool. A single end 75bp sequencing was performed on the Illumina Nextseq 500 by loading 1.8 pM library with 5% PhiX on to a 75 cycle high output flow cell. The RNAseq data was checked for quality using the Illumina FastQC algorithm on Basespace.
Transcriptome analyses RNA-Seq data from small intestine and pancreas was mapped to the mouse reference genome (UCSC/mm10) using Tophat version 2.1.0 (Trapnell et al., 2009 ).
Gene-level sequence counts were extracted for all annotated protein-coding genes using htseqcount version 0.6.1 (Anders et al., 2015) by taking the strict intersection between reads and the transcript models associated with each gene. Raw count data were filtered to remove low expressed genes with less than five counts in any sample. Differentially expressed genes between groups were analyzed using Bioconductor EdgeR package version 3.10.2
Bioconductor/R (McCarthy et al., 2012; Robinson et al., 2010) . Statistically significant differentially expressed genes between groups (Q < 0.05) were selected in gene-wise loglikelihood ratio tests that were corrected for multiple testing by Benjamini and Hochberg FDR.
KEGG pathway enrichment analyses were performed using ClueGo (Bindea et al., 2009; Shannon et al., 2003) to identify pathways in which differentially expressed genes are involved.
A cut-off of 0.4 was set for kappa score and terms including at least 3 genes were retrieved.
Immunostaining and imaging. Organs were dissected, fixed in 10% phosphate-buffered formalin, and processed for paraffin sections. Four-µm sections were dewaxed by immersion in xylene (twice for 5 minutes each time) and hydrated by serial immersion in 100%, 90%, 80%, and 70% ethanol and PBS. (Chen et al., 2018) ) were crossed to CX3CR1-cre mice (described in (Yona et al., 2013) (Hoang et al., 2016) . (e) heat mat of downregulated genes associated with the term zymogen packing (Hoang et al., 2016) . (f) qPCR validation of genes encoding digestive enzymes. Data are shown as mean±sem, *p<0.05, **p<0.01, by nonparametric Mann-Whitney test. ClueGo analysis of significantly down regulated genes shown enrichment of GO term group "very-low-density-lipoprotein-particle" (e). Z-scored heat map of all downregulated genes associated with the GO group "very-low-densitylipoprotein-particle". 
